Neuraxis (NRXS) Gains from Investment Securities (2022 - 2025)
Neuraxis (NRXS) has disclosed Gains from Investment Securities for 4 consecutive years, with -$5506.0 as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities rose 26.52% to -$5506.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13849.0 through Dec 2025, down 1571.73% year-over-year, with the annual reading at $1.3 million for FY2025, 0.0% changed from the prior year.
- Gains from Investment Securities hit -$5506.0 in Q4 2025 for Neuraxis, down from $852214.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.3 million in Q2 2023 to a low of -$1.3 million in Q4 2022.
- Historically, Gains from Investment Securities has averaged $116229.1 across 4 years, with a median of -$5506.0 in 2025.
- Biggest five-year swings in Gains from Investment Securities: crashed 754.16% in 2023 and later soared 12570.44% in 2025.
- Year by year, Gains from Investment Securities stood at -$1.3 million in 2022, then skyrocketed by 95.8% to -$53244.0 in 2023, then soared by 85.93% to -$7493.0 in 2024, then rose by 26.52% to -$5506.0 in 2025.
- Business Quant data shows Gains from Investment Securities for NRXS at -$5506.0 in Q4 2025, $852214.0 in Q3 2025, and $852214.0 in Q2 2025.